{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:21:54Z","timestamp":1761060114962},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"name":"Spanish Ministerio de Sanidad","award":["C11-330 2012","MTM2012-38067-C02-01","Ministerio de Econom\u00eda y Competitividad"],"award-info":[{"award-number":["C11-330 2012","MTM2012-38067-C02-01","Ministerio de Econom\u00eda y Competitividad"]}]},{"name":"Spanish Government"},{"name":"Departament d'Economia i Coneixement of the Generalitat de Catalunya"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1093\/jac\/dkv461","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T19:22:30Z","timestamp":1460575350000},"page":"1346-1351","source":"Crossref","is-referenced-by-count":3,"title":["Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial"],"prefix":"10.1093","volume":"71","author":[{"given":"Josep M.","family":"Llibre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hortensia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Antela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Payeras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jes\u00fas","family":"P\u00e9rez-El\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkaitz","family":"Imaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Masi\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"P\u00e9rez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,1,23]]},"reference":[{"key":"2016041309202563000_71.5.1346.1","first-page":"39","article-title":"HIV-1 genotypic drug resistance interpretation rules\u20142009 Spanish guidelines","volume":"11","author":"de Mendoza","year":"2009","journal-title":"AIDS Rev"},{"key":"2016041309202563000_71.5.1346.2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.16.8621-8632.2003"},{"key":"2016041309202563000_71.5.1346.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5253.1282"},{"key":"2016041309202563000_71.5.1346.4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.4971-4977.2006"},{"key":"2016041309202563000_71.5.1346.5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3851\/IMP2329","article-title":"Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backbone","volume":"18","author":"Waters","year":"2013","journal-title":"Antivir Ther"},{"key":"2016041309202563000_71.5.1346.6","unstructured":"Tashima K , Smeaton L , Andrade A et al . Omitting NRTIs from ARV regimens is not inferior to adding NRTIs in treatment experienced HIV+ subjects failing a PI regimen: the ACTG OPTIONS study. In: Abstracts of the Twentieth Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, USA, 2013. Abstract 153LB. Foundation for Retrovirology and Human Health, Alexandria, VA, USA."},{"key":"2016041309202563000_71.5.1346.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq432"},{"key":"2016041309202563000_71.5.1346.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61164-2"},{"key":"2016041309202563000_71.5.1346.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311274"},{"key":"2016041309202563000_71.5.1346.10","unstructured":"Anta L , de Mendoza C , Soriano V . Red de Investigaci\u00f3n en SIDA (RIS). Gu\u00eda de resistencias a los antirretrovirales 2011 . Barcelona: Publicaciones Permanyer, 2011."},{"key":"2016041309202563000_71.5.1346.11","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents . Department of Health and Human Services. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf ."},{"key":"2016041309202563000_71.5.1346.12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir275"},{"key":"2016041309202563000_71.5.1346.13","doi-asserted-by":"publisher","DOI":"10.1086\/430709"},{"key":"2016041309202563000_71.5.1346.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000218542.08845.b2"},{"key":"2016041309202563000_71.5.1346.15","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200412150-00009"},{"key":"2016041309202563000_71.5.1346.16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/135965350601100608","article-title":"A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial","volume":"11","author":"Fox","year":"2006","journal-title":"Antivir Ther"},{"key":"2016041309202563000_71.5.1346.17","doi-asserted-by":"publisher","DOI":"10.1179\/1528433614Z.0000000015"},{"key":"2016041309202563000_71.5.1346.18","unstructured":"Blanco J , Whitlock G , Cantero I et al . Simplification strategy in heavily pre-treated patients with multi-drug-resistant virus: the STOPNUK study. In: Abstracts of the Seventh IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur, Malaysia, 2013. Abstract PUB007."},{"key":"2016041309202563000_71.5.1346.19","doi-asserted-by":"publisher","DOI":"10.1086\/650732"},{"key":"2016041309202563000_71.5.1346.20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.8.3579-3585.2000"},{"key":"2016041309202563000_71.5.1346.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2376-2379.2003"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/5\/1346\/11280226\/dkv461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T19:44:13Z","timestamp":1655495053000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,23]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,4,13]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1093\/jac\/dkv461"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv461","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,23]]}}}